A novel formulation of theranostic nanomedicine for targeting drug delivery to gastrointestinal tract cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-10-09

AUTHORS

Madeeha Shahzad Lodhi, Muhammad Tahir Khan, Saira Aftab, Zahoor Qadir Samra, Heng Wang, Dong Qing Wei

ABSTRACT

BackgroundTheranostic nanomedicines contain a nanovehicle that has fluorescent properties and can be used for diagnostic, therapeutic and prognostic purposes. The transferrin receptor expression is 1000-fold higher in rapidly growing cancer cells as compared to the normal cells and, therefore, can be used in targeted drug delivery systems. The objective of the present study was to design a novel targeted gold nanoparticle (GNPs)-based theranostic formulation for gastrointestinal (GI) tract-related cancers. The synthesized GNPs were conjugated to transferrin and doxorubicin both separately and collectively to check their cytotoxic properties. The in vitro cytotoxicity of nanocomposites was observed against colon cancer cell line HCT-116. The doxorubicin conjugated nanocomposites showed almost the same cytotoxicity, but more effect at later hours (h). The IC50 and IC100 were 50 µg/ml and 250 µg/ml, respectively, equivalent to the doxorubicin weight for GNP theranostic nanomedicine.ResultsThe maximum effect was observed after 12 h and nanomedicines were still active after 72 h of treatment. Our in vivo data proved that nanomedicine crossed all the barriers and was successfully delivered to the tumour cells. Theranostic nanomedicine’s (TNM) effect on body weight and survival rate on mice was many folds better than mice in pure doxorubicin group. It also showed almost 80% survival rate on day 40. The in vivo and in vitro results show the effects of prolonged drug release and the nanomedicine was not toxic to vital organs of the animal.ConclusionThis is one of its kind studies in which a novel targeted nanomedicines approach was formulated for therapeutic as well as prognostic purposes against GI tract cancer.Graphic Abstract More... »

PAGES

26

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12645-021-00098-4

DOI

http://dx.doi.org/10.1186/s12645-021-00098-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1141763172


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan", 
          "id": "http://www.grid.ac/institutes/grid.440564.7", 
          "name": [
            "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lodhi", 
        "givenName": "Madeeha Shahzad", 
        "id": "sg:person.015203065237.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015203065237.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan", 
          "id": "http://www.grid.ac/institutes/grid.440564.7", 
          "name": [
            "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Khan", 
        "givenName": "Muhammad Tahir", 
        "id": "sg:person.015572452620.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015572452620.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan", 
          "id": "http://www.grid.ac/institutes/grid.440564.7", 
          "name": [
            "Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aftab", 
        "givenName": "Saira", 
        "id": "sg:person.012323352117.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012323352117.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan", 
          "id": "http://www.grid.ac/institutes/grid.11173.35", 
          "name": [
            "Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Samra", 
        "givenName": "Zahoor Qadir", 
        "id": "sg:person.01215704533.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215704533.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China", 
          "id": "http://www.grid.ac/institutes/grid.16821.3c", 
          "name": [
            "State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Heng", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peng Cheng Laboratory, Vanke Cloud City Phase I Building 8, Xili Street, Nashan District, 518055, Shenzhen, Guangdong, People\u2019s Republic of China", 
          "id": "http://www.grid.ac/institutes/grid.508161.b", 
          "name": [
            "State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China", 
            "Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University, 200240, Shanghai, China", 
            "Peng Cheng Laboratory, Vanke Cloud City Phase I Building 8, Xili Street, Nashan District, 518055, Shenzhen, Guangdong, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wei", 
        "givenName": "Dong Qing", 
        "id": "sg:person.0711767431.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711767431.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/srep21225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019159708", 
          "https://doi.org/10.1038/srep21225"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-10-09", 
    "datePublishedReg": "2021-10-09", 
    "description": "BackgroundTheranostic nanomedicines contain a nanovehicle that has fluorescent properties and can be used for diagnostic, therapeutic and prognostic purposes. The transferrin receptor expression is 1000-fold higher in rapidly growing cancer cells as compared to the normal cells and, therefore, can be used in targeted drug delivery systems. The objective of the present study was to design a novel targeted gold nanoparticle (GNPs)-based theranostic formulation for gastrointestinal (GI) tract-related cancers. The synthesized GNPs were conjugated to transferrin and doxorubicin both separately and collectively to check their cytotoxic properties. The in vitro cytotoxicity of nanocomposites was observed against colon cancer cell line HCT-116. The doxorubicin conjugated nanocomposites showed almost the same cytotoxicity, but more effect at later hours (h). The IC50 and IC100 were 50\u00a0\u00b5g/ml and 250\u00a0\u00b5g/ml, respectively, equivalent to the doxorubicin weight for GNP theranostic nanomedicine.ResultsThe maximum effect was observed after 12\u00a0h and nanomedicines were still active after 72\u00a0h of treatment. Our in vivo data proved that nanomedicine crossed all the barriers and was successfully delivered to the tumour cells. Theranostic nanomedicine\u2019s (TNM) effect on body weight and survival rate on mice was many folds better than mice in pure doxorubicin group. It also showed almost 80% survival rate on day 40. The in vivo and in vitro results show the effects of prolonged drug release and the nanomedicine was not toxic to vital organs of the animal.ConclusionThis is one of its kind studies in which a novel targeted nanomedicines approach was formulated for therapeutic as well as prognostic purposes against GI tract cancer.Graphic Abstract", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12645-021-00098-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.8943040", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1042272", 
        "issn": [
          "1868-6958", 
          "1868-6966"
        ], 
        "name": "Cancer Nanotechnology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "theranostic nanomedicine", 
      "cytotoxicity of nanocomposites", 
      "synthesized GNPs", 
      "drug delivery systems", 
      "conjugated nanocomposite", 
      "theranostic formulations", 
      "gold nanoparticles", 
      "nanomedicine", 
      "nanomedicine approaches", 
      "drug delivery", 
      "delivery system", 
      "tract cancer", 
      "drug release", 
      "nanocomposites", 
      "survival rate", 
      "prognostic purposes", 
      "fluorescent properties", 
      "gastrointestinal tract cancer", 
      "GI tract cancers", 
      "same cytotoxicity", 
      "transferrin receptor expression", 
      "nanoparticles", 
      "Graphic abstract", 
      "doxorubicin group", 
      "nanovehicles", 
      "receptor expression", 
      "cancer cell line HCT-116", 
      "cell line HCT-116", 
      "body weight", 
      "colon cancer cell line HCT-116", 
      "vital organs", 
      "tumor cells", 
      "day 40", 
      "novel formulation", 
      "cancer cells", 
      "cancer", 
      "GNP", 
      "normal cells", 
      "maximum effect", 
      "vivo data", 
      "mice", 
      "cytotoxicity", 
      "HCT-116", 
      "present study", 
      "properties", 
      "novel", 
      "cells", 
      "delivery", 
      "cytotoxic properties", 
      "doxorubicin", 
      "ConclusionThis", 
      "IC100", 
      "effect", 
      "treatment", 
      "weight", 
      "IC50", 
      "vivo", 
      "organs", 
      "later hours", 
      "study", 
      "animals", 
      "rate", 
      "hours", 
      "transferrin", 
      "formulation", 
      "more effect", 
      "group", 
      "expression", 
      "release", 
      "kind study", 
      "purpose", 
      "system", 
      "barriers", 
      "objective", 
      "approach", 
      "folds", 
      "data", 
      "results", 
      "Abstract"
    ], 
    "name": "A novel formulation of theranostic nanomedicine for targeting drug delivery to gastrointestinal tract cancer", 
    "pagination": "26", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1141763172"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12645-021-00098-4"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12645-021-00098-4", 
      "https://app.dimensions.ai/details/publication/pub.1141763172"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-10T10:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_909.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12645-021-00098-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12645-021-00098-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12645-021-00098-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12645-021-00098-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12645-021-00098-4'


 

This table displays all metadata directly associated to this object as RDF triples.

188 TRIPLES      22 PREDICATES      105 URIs      96 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12645-021-00098-4 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N02e44a52e8a0456193f6f274d93ec0fe
4 schema:citation sg:pub.10.1038/srep21225
5 schema:datePublished 2021-10-09
6 schema:datePublishedReg 2021-10-09
7 schema:description BackgroundTheranostic nanomedicines contain a nanovehicle that has fluorescent properties and can be used for diagnostic, therapeutic and prognostic purposes. The transferrin receptor expression is 1000-fold higher in rapidly growing cancer cells as compared to the normal cells and, therefore, can be used in targeted drug delivery systems. The objective of the present study was to design a novel targeted gold nanoparticle (GNPs)-based theranostic formulation for gastrointestinal (GI) tract-related cancers. The synthesized GNPs were conjugated to transferrin and doxorubicin both separately and collectively to check their cytotoxic properties. The in vitro cytotoxicity of nanocomposites was observed against colon cancer cell line HCT-116. The doxorubicin conjugated nanocomposites showed almost the same cytotoxicity, but more effect at later hours (h). The IC50 and IC100 were 50 µg/ml and 250 µg/ml, respectively, equivalent to the doxorubicin weight for GNP theranostic nanomedicine.ResultsThe maximum effect was observed after 12 h and nanomedicines were still active after 72 h of treatment. Our in vivo data proved that nanomedicine crossed all the barriers and was successfully delivered to the tumour cells. Theranostic nanomedicine’s (TNM) effect on body weight and survival rate on mice was many folds better than mice in pure doxorubicin group. It also showed almost 80% survival rate on day 40. The in vivo and in vitro results show the effects of prolonged drug release and the nanomedicine was not toxic to vital organs of the animal.ConclusionThis is one of its kind studies in which a novel targeted nanomedicines approach was formulated for therapeutic as well as prognostic purposes against GI tract cancer.Graphic Abstract
8 schema:genre article
9 schema:inLanguage en
10 schema:isAccessibleForFree true
11 schema:isPartOf N1206493e424342ddbbdef0ee868a0464
12 N79d7d0de8f644f939a085fc598e75466
13 sg:journal.1042272
14 schema:keywords Abstract
15 ConclusionThis
16 GI tract cancers
17 GNP
18 Graphic abstract
19 HCT-116
20 IC100
21 IC50
22 animals
23 approach
24 barriers
25 body weight
26 cancer
27 cancer cell line HCT-116
28 cancer cells
29 cell line HCT-116
30 cells
31 colon cancer cell line HCT-116
32 conjugated nanocomposite
33 cytotoxic properties
34 cytotoxicity
35 cytotoxicity of nanocomposites
36 data
37 day 40
38 delivery
39 delivery system
40 doxorubicin
41 doxorubicin group
42 drug delivery
43 drug delivery systems
44 drug release
45 effect
46 expression
47 fluorescent properties
48 folds
49 formulation
50 gastrointestinal tract cancer
51 gold nanoparticles
52 group
53 hours
54 kind study
55 later hours
56 maximum effect
57 mice
58 more effect
59 nanocomposites
60 nanomedicine
61 nanomedicine approaches
62 nanoparticles
63 nanovehicles
64 normal cells
65 novel
66 novel formulation
67 objective
68 organs
69 present study
70 prognostic purposes
71 properties
72 purpose
73 rate
74 receptor expression
75 release
76 results
77 same cytotoxicity
78 study
79 survival rate
80 synthesized GNPs
81 system
82 theranostic formulations
83 theranostic nanomedicine
84 tract cancer
85 transferrin
86 transferrin receptor expression
87 treatment
88 tumor cells
89 vital organs
90 vivo
91 vivo data
92 weight
93 schema:name A novel formulation of theranostic nanomedicine for targeting drug delivery to gastrointestinal tract cancer
94 schema:pagination 26
95 schema:productId N3738cc8a412141e28a2524bd9b9d2b11
96 N8e39b4b88e234693bb2ca572a3dd6756
97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1141763172
98 https://doi.org/10.1186/s12645-021-00098-4
99 schema:sdDatePublished 2022-05-10T10:31
100 schema:sdLicense https://scigraph.springernature.com/explorer/license/
101 schema:sdPublisher Nfc98ae99ecd54ddcb207ecc8b164c890
102 schema:url https://doi.org/10.1186/s12645-021-00098-4
103 sgo:license sg:explorer/license/
104 sgo:sdDataset articles
105 rdf:type schema:ScholarlyArticle
106 N02e44a52e8a0456193f6f274d93ec0fe rdf:first sg:person.015203065237.50
107 rdf:rest Nc7745464446247f6ba5c19fbbf1cf6e1
108 N1206493e424342ddbbdef0ee868a0464 schema:issueNumber 1
109 rdf:type schema:PublicationIssue
110 N14986339aeb4400bb5a471bf1dfc7ee7 rdf:first N5d24e993783b48328e2415853aaaad2a
111 rdf:rest N7d37da381d7b4e71976bfa12fd980edb
112 N1e51b0e4b74c46fbae690f0e7f9e1b5a rdf:first sg:person.012323352117.10
113 rdf:rest N3d4f5acdbefc467381b71eff1e6b5584
114 N3738cc8a412141e28a2524bd9b9d2b11 schema:name dimensions_id
115 schema:value pub.1141763172
116 rdf:type schema:PropertyValue
117 N3d4f5acdbefc467381b71eff1e6b5584 rdf:first sg:person.01215704533.26
118 rdf:rest N14986339aeb4400bb5a471bf1dfc7ee7
119 N5d24e993783b48328e2415853aaaad2a schema:affiliation grid-institutes:grid.16821.3c
120 schema:familyName Wang
121 schema:givenName Heng
122 rdf:type schema:Person
123 N79d7d0de8f644f939a085fc598e75466 schema:volumeNumber 12
124 rdf:type schema:PublicationVolume
125 N7d37da381d7b4e71976bfa12fd980edb rdf:first sg:person.0711767431.18
126 rdf:rest rdf:nil
127 N8e39b4b88e234693bb2ca572a3dd6756 schema:name doi
128 schema:value 10.1186/s12645-021-00098-4
129 rdf:type schema:PropertyValue
130 Nc7745464446247f6ba5c19fbbf1cf6e1 rdf:first sg:person.015572452620.25
131 rdf:rest N1e51b0e4b74c46fbae690f0e7f9e1b5a
132 Nfc98ae99ecd54ddcb207ecc8b164c890 schema:name Springer Nature - SN SciGraph project
133 rdf:type schema:Organization
134 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
135 schema:name Medical and Health Sciences
136 rdf:type schema:DefinedTerm
137 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
138 schema:name Oncology and Carcinogenesis
139 rdf:type schema:DefinedTerm
140 sg:grant.8943040 http://pending.schema.org/fundedItem sg:pub.10.1186/s12645-021-00098-4
141 rdf:type schema:MonetaryGrant
142 sg:journal.1042272 schema:issn 1868-6958
143 1868-6966
144 schema:name Cancer Nanotechnology
145 schema:publisher Springer Nature
146 rdf:type schema:Periodical
147 sg:person.01215704533.26 schema:affiliation grid-institutes:grid.11173.35
148 schema:familyName Samra
149 schema:givenName Zahoor Qadir
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215704533.26
151 rdf:type schema:Person
152 sg:person.012323352117.10 schema:affiliation grid-institutes:grid.440564.7
153 schema:familyName Aftab
154 schema:givenName Saira
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012323352117.10
156 rdf:type schema:Person
157 sg:person.015203065237.50 schema:affiliation grid-institutes:grid.440564.7
158 schema:familyName Lodhi
159 schema:givenName Madeeha Shahzad
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015203065237.50
161 rdf:type schema:Person
162 sg:person.015572452620.25 schema:affiliation grid-institutes:grid.440564.7
163 schema:familyName Khan
164 schema:givenName Muhammad Tahir
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015572452620.25
166 rdf:type schema:Person
167 sg:person.0711767431.18 schema:affiliation grid-institutes:grid.508161.b
168 schema:familyName Wei
169 schema:givenName Dong Qing
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711767431.18
171 rdf:type schema:Person
172 sg:pub.10.1038/srep21225 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019159708
173 https://doi.org/10.1038/srep21225
174 rdf:type schema:CreativeWork
175 grid-institutes:grid.11173.35 schema:alternateName Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan
176 schema:name Institute of Biochemistry and Biotechnology, University of the Punjab, Lahore, Pakistan
177 rdf:type schema:Organization
178 grid-institutes:grid.16821.3c schema:alternateName State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China
179 schema:name State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China
180 rdf:type schema:Organization
181 grid-institutes:grid.440564.7 schema:alternateName Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan
182 schema:name Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Defence Road Lahore, Postal code: 58810, Lahore, Pakistan
183 rdf:type schema:Organization
184 grid-institutes:grid.508161.b schema:alternateName Peng Cheng Laboratory, Vanke Cloud City Phase I Building 8, Xili Street, Nashan District, 518055, Shenzhen, Guangdong, People’s Republic of China
185 schema:name Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education, Shanghai Jiao Tong University, 200240, Shanghai, China
186 Peng Cheng Laboratory, Vanke Cloud City Phase I Building 8, Xili Street, Nashan District, 518055, Shenzhen, Guangdong, People’s Republic of China
187 State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai, China
188 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...